These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1352370)

  • 21. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma.
    Slats AM; Sont JK; van Klink RH; Bel EH; Sterk PJ
    Chest; 2006 Jul; 130(1):58-65. PubMed ID: 16840383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF
    Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic and screening capacities of peak expiratory flow measurements in the assessment of airway obstruction and bronchodilator response in children with asthma.
    Slieker MG; van der Ent CK
    Monaldi Arch Chest Dis; 2003; 59(2):155-9. PubMed ID: 14635506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Blais CM; Davis BE; Cockcroft DW
    Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of bronchodilator response in children with asthma. Dutch CNSLD Study Group.
    Waalkens HJ; Merkus PJ; van Essen-Zandvliet EE; Brand PL; Gerritsen J; Duiverman EJ; Kerrebijn KF; Knol KK; Quanjer PH
    Eur Respir J; 1993 May; 6(5):645-51. PubMed ID: 8519373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of bronchodilator response in patients with airway obstruction.
    Quadrelli SA; Roncoroni AJ; Montiel GC
    Respir Med; 1999 Sep; 93(9):630-6. PubMed ID: 10542976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.
    Panettieri RA; MacIntyre N; Sims M; Kerwin E; Fogarty C; Noonan M; Claus R; Andrews WT
    Clin Ther; 2009 Aug; 31(8):1716-23. PubMed ID: 19808130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed airways obstruction among patients with severe asthma: findings from the Singapore General Hospital-Severe Asthma Phenotype Study.
    Yii AC; Tan GL; Tan KL; Lapperre TS; Koh MS
    BMC Pulm Med; 2014 Dec; 14():191. PubMed ID: 25467558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative functional criteria to assess airflow-limitation reversibility in asthma.
    Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A
    Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.